Key Highlights

  • 0.13 USD is the consensus loss per share estimate for ASP Isotopes Inc. (NASDAQ:ASPI) for the quarter ending September 30, 2026, which compares with an adjusted headline loss of USD 0.25 per share in the second quarter.
  • 5.1 million USD was the second quarter 2026 Revenue of ASP Isotopes Inc. (NASDAQ:ASPI), up from USD 1.2 million a year earlier, with Gross Profit of USD 1.5 million versus USD 0.6 million.
  • 254.9 million USD is the calculated total of cash and equivalents of USD 219.6 million and short-term investments of USD 35.3 million held by the company at June 30, 2026.
  • 1.16 billion USD is the estimated cost of Phase 2 of the Virginia Gas Project, for which ASP Isotopes Inc. (NASDAQ:ASPI) is working to secure senior Debt funding.

What Investors Expect From ASP Isotopes Inc. (NASDAQ:ASPI) on November 16, 2026

ASP Isotopes is scheduled to report third quarter 2026 results on Monday, November 16, 2026. The consensus estimate calls for a loss of USD 0.13 per share, based on a single analyst, against an adjusted headline loss of USD 0.25 per share in the second quarter and USD 0.05 in the first quarter. The company has a market Capitalization of roughly USD 310 million, based on 153.31 million shares outstanding and a price of USD 2.02 on October 26, 2026. Published market data shows trailing twelve-month Earnings of negative USD 0.70 per share, and the shares are down 54.1% since August 14.

The Rationale: Last Reported Quarter and Management Outlook for ASP Isotopes Inc. (NASDAQ:ASPI)

Second quarter operating expenses were USD 35.7 million, up from USD 12.5 million, while the net loss from continuing operations narrowed to USD 34.0 million from USD 75.1 million, mainly because Fair Value adjustments on convertible notes were lower. Revenue growth came from acquisitions, including Renergen, which closed on January 6, 2026 and added helium and LNG production. Skyline Builders was deconsolidated effective March 29, 2026, and the company retains an 8.6% stake. The company reports three segments: specialist isotopes, nuclear fuels, and helium and LNG. Management targets initial commercial shipments of enriched carbon-14, silicon-28 and ytterbium-176 in the second half of 2026, and on October 26, 2026 announced stable liquid helium production at the Virginia Gas Project.

Valuation, Liquidity and Risks for ASP Isotopes Inc. (NASDAQ:ASPI)

Published Balance Sheet data shows total debt of USD 269.54 million against cash of USD 254.90 million, a calculated net debt position of USD 14.65 million. Management expects existing liquidity to fund operations for more than 12 months, while acknowledging that further capital will probably be needed for growth projects and the USD 1.16 billion second phase of the Virginia Gas Project. Risks include delays in commissioning and isotope shipments, dependence on convertible financing, share price volatility, fair value swings that distort reported losses, and execution risk.

Where Things Stand

ASP Isotopes Inc. (NASDAQ:ASPI) reports on November 16, 2026 as a company in transition from development to early commercial production. Second quarter revenue of USD 5.1 million was more than four times the USD 1.2 million of a year earlier, but operating expenses of USD 35.7 million kept the net loss from continuing operations at USD 34.0 million. Liquidity of USD 254.9 million supports management's view of more than 12 months of funding, while debt of USD 269.54 million and a USD 1.16 billion project phase underline the capital intensity. The consensus loss of USD 0.13 per share will test progress in helium output and isotope shipments.